Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Journal of Gastroenterology
Published in: Clinical Journal of Gastroenterology 5/2020

01-10-2020 | Endoscopy | Case Report

Iron pill induced gastritis causing severe anemia

Authors: Kiran Motwani, Jonah Rubin, Harris Yfantis, Megan Willard

Published in: Clinical Journal of Gastroenterology | Issue 5/2020

Login to get access

Abstract

Iron supplementation is ubiquitously prescribed and considered a benign means of therapy. However, side effects such as iron pill gastritis can be life threatening prompting discontinuation. We describe a case of a 71-year-old man who presents with severe iron deficiency anemia on oral iron therapy. Esophagogastroduodenoscopy revealed mucosal injury in the fundus, including erythema and ulceration. Biopsy of the area was significant for pill debris. After switching to intravenous iron supplementation, his gastric mucosa healed and anemia improved. This case demonstrates the rare life-threatening side effect of iron pills causing corrosive mucosal damage and significant anemia from gastrointestinal bleeding.
Literature
1.
Short M, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013;87:98–104.PubMed
2.
Niv E, Elis A, Zissin R, et al. Iron deficiency anemia in patients without gastrointestinal symptoms—a prospective study. Fam Pract. 2005;22:58–61.CrossRefPubMed
3.
Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci. 2010;55:548–59.CrossRefPubMed
4.
Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118:1142.CrossRefPubMed
5.
Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016;316:2025–35.CrossRefPubMed
6.
Gasche C, Lomer MCE, Cavill I, et al. Iron, anemia, and inflammatory bowel disease. Gut. 2004;53:1190–7.CrossRefPubMed
7.
Sawaya RA, Jaffe J, Friedenberg L, et al. Vitamin, mineral, and drug absorption following bariatric surgery. Curr Drug Metab. 2012;13:1345–55.CrossRefPubMed
8.
Avni T, Bieber A, Grossman A, et al. Safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90:12–23.CrossRefPubMed
9.
Laine LA, Bentley E, Chandrasoma P. Effect of oral iron therapy on the upper gastrointestinal tract. A prospective evaluation. Dig Dis Sci. 1988;33:172–7.CrossRefPubMed
10.
Hashash JG, Proksell S, Kuan SF, et al. Iron pill-induced gastritis. ACG Case Rep J. 2013;1:13–5.CrossRefPubMed
11.
Kothadia JP, Arju R, Kaminski M. Gastric siderosis: an under-recognized and rare clinical entity. SAGE Open Med. 2016;4:1–8.CrossRef
12.
Kaye P, Abdulla K, Wood J, et al. Iron-induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy. Histopathology. 2008;53:311–7.CrossRefPubMed
13.
Abraham SC, Yardley JH, Wu TT. Erosive injury to the upper gastrointestinal tract in patient receiving iron medication: an underrecognized entity. Am J Surg Pathol. 1999;23:1241–7.CrossRefPubMed
14.
Melit LE, Marginean CO, Mocanu S, et al. A rare care of iron-pill induced gastritis in a female teenager. Medicine. 2017;96:1–4.CrossRef
Metadata
Title
Iron pill induced gastritis causing severe anemia
Authors
Kiran Motwani
Jonah Rubin
Harris Yfantis
Megan Willard
Publication date
01-10-2020
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 5/2020
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-020-01141-4

Other articles of this Issue 5/2020

Clinical Journal of Gastroenterology 5/2020 Go to the issue

Case Report

Two independent families with strongly suspected hereditary diffuse gastric cancer based on the probands’ endoscopic findings

Case Report

RETRACTED ARTICLE: Perforated isolated jejunal diverticula: a rare cause of acute abdomen

Case Report

Exacerbation of psoriasis vulgaris by sorafenib treatment for hepatocellular carcinoma

Case Report

A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk

Case Report

Surgical intervention for portal hypertension caused by oxaliplatin-based chemotherapy: a case report and a review of literature regarding radiological and/or surgical interventions for oxaliplatin-associated portal hypertension

Case Report

Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits